Published in Medical Verdicts and Law Weekly, December 28th, 2006
In its ruling, the court approved the INEX plan of arrangement to transfer all of the company's transferable assets and liabilities to Tekmira. This includes the 2001 agreements that created Protiva Biotherapeutics, Inc., and the ongoing litigation with Protiva.
The court rejected all motions raised by Protiva to block the spin-out of Tekmira.
On September 20, 2006 shareholders of INEX voted 99.3% in favor of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.